Contact this trialFirst, we need to learn more about you.
Immunosuppressant
Hand Transplant + Belatacept for Limb Loss Therapy
Recruiting1 awardPhase 2
Durham, North Carolina
This trial is testing the safety and efficacy of hand transplants for people who have lost their limbs below the elbow. The primary endpoint is the ability to use the transplanted limb in activities of daily living at 18 months after transplantation, as measured by a quantitative functional test.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.